In this study, the effects of Kinesio Taping methods applied in combination with Schroth therapy on pain and functional capacity in young adults diagnosed with idiopathic scoliosis will be evaluated.
This study is designed as a randomized controlled trial. Participants will be randomly assigned to one of three groups:
Group 1: Schroth therapy combined with Kinesio Taping
Group 2: Schroth therapy alone
Group 3: Schroth therapy combined with sham Kinesio Taping
Kinesio Taping will be applied for 4 weeks. The tape will remain in place for 5 consecutive days, followed by a 2-day rest period for the skin, and this cycle will be repeated throughout the intervention period.
Schroth therapy will be administered 3 times per week for 4 weeks.
Assessments will be conducted at baseline (Week 0), during treatment (Week 2), at the end of treatment (Week 4), and at follow-up (Week 8).
The primary outcome measures will be pain intensity assessed by the Numeric Rating Scale (NRS) and functional disability assessed by the Oswestry Disability Index (ODI). Secondary outcome measures will include the Scoliosis Research Society-22 (SRS-22) questionnaire and the Patient Global Impression of Change (PGIC) scale.
Individuals aged between 18 and 30 years.
Radiologically confirmed diagnosis of idiopathic scoliosis.
Cobb angle between 10° and 30° and considered candidates for conservative treatment.
Risser stage 5.
Diagnosis of non-structural (functional) scoliosis, congenital scoliosis, or neuromuscular scoliosis.
History of previous spinal surgery.
Participation in scoliosis-specific exercise therapy within the last 6 months.
Presence of open wounds, dermatological conditions, or allergy to taping materials.
Parallel
Schroth Terapisi
Other interventionSchroth therapy is a scoliosis-specific exercise program designed to address three-dimensional spinal deformities. The intervention includes individualized corrective exercises, rotational angular breathing techniques, postural alignment training, trunk muscle stabilization, and muscular symmetry exercises. Sessions will be supervised by a certified physiotherapist three times per week for 4 weeks.
Kinesio Taping
Other interventionKinesio Taping will be applied using elastic therapeutic tape with corrective tension techniques targeting spinal alignment and paraspinal muscle facilitation. The tape will remain in place for 5 consecutive days followed by a 2-day rest period. This cycle will be repeated throughout the 4-week intervention period.
Sham Kinesio Taping
Other interventionSham Kinesio Taping will be applied using elastic therapeutic tape without therapeutic tension and without corrective technique. The tape will be placed in a non-corrective manner that does not aim to influence spinal alignment or muscle facilitation. The application schedule will be identical to the experimental taping group (5 days on, 2 days off for 4 weeks) to maintain participant blinding.
Change in Pain Intensity (NRS)
Pain intensity will be assessed using the Numeric Rating Scale (NRS), scale ranging from 0 (no pain) to 10 (worst imaginable pain). Changes in pain intensity will be evaluated across all assessment time points during the study
Change in Functional Disability (ODI)
Functional disability will be assessed using the Oswestry Disability Index (ODI), a validated questionnaire designed to measure disability related to low back pain. The ODI consists of 10 items evaluating daily living activities, with higher scores indicating greater disability. Changes in functional disability will be evaluated across the specified assessment time points.
Change in Scoliosis-Specific Quality of Life (SRS-22)
Quality of life will be assessed using the Scoliosis Research Society-22 (SRS-22) questionnaire, a scoliosis-specific, validated instrument that evaluates function/activity, pain, self-image, mental health, and satisfaction with management. Higher scores indicate better health-related quality of life. Changes in SRS-22 scores will be evaluated across the specified assessment time points.
Patient Global Impression of Change (PGIC)
Global perceived improvement will be assessed using the Patient Global Impression of Change (PGIC) scale, a patient-reported outcome measure evaluating overall change in condition following treatment. The PGIC is a 7-point scale ranging from "very much worse" to "very much improved."
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
